The MM+M Podcast

What makes a healthcare brand stick? In this episode, VCCP Health unpacks CHESS moves: Character, Humor, Emotion, Surprise and Sonic Branding, and how they help brands move beyond awareness to become truly memorable. We explore how building memory structures, not just messaging, drives trust, behavior change and long-term brand impact. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Over the past week, everyone has had launches on the brain – thanks largely to the Artemis II rocket and its ongoing lunar flyby mission. However, there are a couple of health-related launches that are the focus of this week’s episode. First up is the launch of HayloARC, a health-focused demand-side platform – better known as a DSP. HayloARC is available for use by advertisers and medical marketing agencies seeking to better interface with HCPs and patients. To accomplish this, HayloARC utilizes first-party HCP data derived from 30-plus medical publications owned by Haymarket Media, the parent company of MM+M. For the feature conversation, editor-at-large Steve Madden sits down with Louis Naimoli, VP of programmatic business development and strategy at Haymarket, about what HayloARC is, how it’s differentiated from other DSPs and what it offers programmatic buyers in medical marketing. Then, during our Trends segment, we’re talking about how the fight for GLP-1 supremacy between Novo Nordisk and Eli Lilly has shifted to the oral obesity pill battlefield. We discuss Novo rolling out a multimonth subscription program for Wegovy and the FDA’s approval of Lilly’s daily oral weight loss drug Foundayo. Music: “Deep Reflection” by DP and Triple Scoop Music. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

At one point in time not too long ago, Weight Watchers was the legacy name in weight loss treatment. Armed with an endorsement from board member Oprah Winfrey, everything was turning up Weight Watchers – until it wasn’t.. Usurped by powerful weight loss drugs manufactured by Eli Lilly and Novo Nordisk – along with ascendant telehealth firms like Ro, Hims & Hers, and Noom – Weight Watchers went into significant decline.  Ultimately, even Oprah left the company and donated her shares.  In May 2025, Weight Watchers filed for Chapter 11 bankruptcy in order to eliminate around $1.5 billion in debt. It emerged from bankruptcy in July and now has its sights set on repositioning itself as a key player in the GLP-1 age. But what is Weight Watchers’ function in 2026?  This week, managing editor Jack O’Brien is joined by Scott Honken, PharmD, chief commercial officer at Weight Watchers, for an update on the company’s current standing in the GLP-1 landscape, where it’s been and where it’s going. In lieu of our Trends segment, we have some audio takeouts from Jack’s time at SXSW, featuring leaders from Amgen, Marina Maher Communications and Compass Pathways. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The world of pharma marketing continues to evolve with multiple ongoing challenges: creating more results with less resources, navigating political and economic uncertainties, overcoming a less than favorable industry public perception and adapting to the ever-present impact of AI. What remains in place throughout all of these variables is the client and AOR relationship. In this podcast we discuss multiple ways in which this relationship can evolve to help foster stronger, truer strategic partnership resulting in greater wins and achievement for both sides. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

If you followed along with managing editor Jack O’Brien’s live blog from SXSW last week, you’ll know that he spoke with a number of key medical marketing leaders on the ground in Austin. Those takeouts, including insights from Amgen, Marina Maher Communications and Compass Pathways, will be featured in next week’s podcast. For this week’s pod, we have an important conversation further tying in pharma brands to the world of sports.  We’re joined by Pro Football Hall of Famer Barry Sanders, who serves as a spokesperson for Amgen in its campaign raising awareness about cardiovascular disease, namely LDL, or “bad” cholesterol. Sanders, who suffered a heart attack in 2024, has partnered with the pharma giant to use his stature as the greatest living running back to raise awareness around LDL-C testing. He has starred in The Making of a Heart Attack documentary sponsored by Amgen and also participated in a panel discussion about the issue at SXSW. And for our Trends segment, you’ll hear from Jameson Fleming, Steve Madden, Lecia Bushak with a preview of the 2026 MM+M Transform conference scheduled for next Tuesday, March 31 in downtown Manhattan.   Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of our ongoing series celebrating MM+M’s 60th Anniversary, editor-at-large Steve Madden sits down with David Paragamian, CEO of Health Monitor Network, to explore the principles that drive successful leadership in the pharmaceutical and marketing industries. Paragamian shares insights from his professional journey to explain why intentionality is the secret to effective recruitment and team building. They discuss how small projects can offer the most significant leadership breakthroughs, the non-negotiable value of writing and communication in business, why true resilience is forged through personal challenges rather than just corporate ones and the formative experience of working for P&G right out of college. And in this week's Trends segment, Madden and MM+M editor-in-chief Jameson Fleming dive into the "therapeutic" power of writing, reflect on Madden's book Embrace the Suck and discuss the modern challenge of balancing a high-stakes career with family life and personal passions like CrossFit. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ahead of SXSW, this interview with Justin Freid, chief media & innovation officer explores CMI Media Group's insights into the emerging technologies and cross-industry innovations set to reshape healthcare marketing and patient engagement. It specifically addresses how artificial intelligence is revolutionizing media planning, personalizing experiences and enhancing communication with healthcare professionals, alongside the unique opportunities and challenges it presents for pharma marketers. The discussion ultimately reveals how these advancements, driven by the "consumerization of healthcare," will demand innovative digital solutions and communication strategies from brands in the immediate future. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

When MM+M set out to hire a new reporter, there were a few characteristics that we were looking for. We wanted a reporter who was able to file clean copy on tight deadlines while also possessing the soft skills to effectively network and participate in our live events.  Most of the reporters we interviewed fit the bill, so one of the differentiators would ultimately come down to experience with healthcare reporting and covering our little corner of the world. That’s where Bella Czajkowski stood out. Bella joined MM+M with great familiarity of the healthcare industry, both from her time most recently spent as the newsletter editor for Essen Health Care, as well as working at Kaiser Health News’ Arm and a Leg podcast and the Global Health Reporting Center. Yet it was her work as the national correspondent for The 340B Report – covering an arcane, opaque federal health program – that stood out most. That’s why we’re spending this week’s episode formally welcoming her on to the podcast, unpacking what she’s learned over the first month on the job and what she hopes to achieve as part of the MM+M team going forward. And for our Trends segment, we’re talking about the coming end of Vinay Prasad’s chaotic tenure at the FDA. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Regulations governing AI are more than likely on their way – but a lot of unknowns remain. Some might say too many unknowns remain, which isn’t great for business. While clear, comprehensive regulations for AI are widely expected – and requested – by nearly every sector of the economy, there’s plenty we don’t know.  That said, business leaders can not and will not operate in the dark.  Executives in our orbit, whether leading drug manufacturers, major medical marketing agencies or health media companies, require at least a sense of what’s on the horizon. This week, pharma editor Lecia Bushak speaks with Darshan Kulkarni, a pharma regulatory consultant and founding partner at his namesake law firm. Their conversation explores the potential of new laws and regulations around AI use cases in medical marketing, such as digital avatars. And for our Trends segment, we’re talking about Bayer’s lawsuit against Johnson & Johnson for its marketing practices around a prostate cancer drug. Plus, we are graced with a dramatic reading of Steve Madden’s satirical FDA Untitled Letter to ESPN over their faux pharma ad for March Madness.   Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Since podcasting came into existence in the mid-2000s, the space has become increasingly popular, remarkably lucrative and unquestionably saturated. Still, despite the countless millions of podcasts out there, countless millions of people tune in every hour of every day for conversations about every topic – including healthcare.  Joining a world occupied by This Past Weekend, Good Hang and The MM+M Podcast is The Persistence Lab. Launched by AbbVie’s corporate affairs team, The Persistence Lab is the pharma giant’s 10-episode project to highlight the work undertaken by its researchers, the clinical expertise of HCPs as well as the lived experiences of patients.  The first episode of The Persistence Lab was released late last week and is available wherever you listen to your podcasts.Molly James-Lundak, VP of R&D communications at AbbVie, joined me for a slightly meta conversation about joining the podcast sphere, how the drugmaker brought the idea to life and why it was important to engage with audio content creation.   And for our Trends segment, we’re talking about AI in healthcare: Including the tools that actually work, the regulations on the way and the concerns that never go away.  Music: “Deep Reflection” by DP and Triple Scoop Music.   Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On today’s episode, we take a trip back to 1966 – when MM+M was born.A fledgling newsletter focused on pharma advertising, MM+M has since grown into an award-winning publication with digital elements like our website – mmm-online.com – our social media platforms and even this podcast you’re listening to.To walk us through the brand’s beginnings in a small office in southwestern Connecticut to its acquisition by David Gideon in the early 1980s – is Adam Arnegger, executive director of investment at WPP Media.Adam is not only an adland vet of over 25 years, he’s also the grandson of Captain Jack Sullivan, who founded MM+M in 1966.He recently came to our office in Chelsea for a conversation centered around the brand’s diamond anniversary, his grandfather’s vision for the publication and the Captain Jack Sullivan Founder Award that will be presented at the 2026 MM+M Awards ceremony in October.As for our Trends segment, we’re talking about the increasing silliness of the ongoing FDA warning letter spree. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

It’s time to welcome back MM+M’s live events for 2026.On Wednesday evening, we’ll honor this year’s 40 Under 40 class at a dinner and ceremony in midtown Manhattan.To help preview the festivities is 2026 MM+M 40 Under 40 honoree Shonel Morrison, head of media strategy at AstraZeneca.With more than 14 years of medical marketing experience, Morrison had stints at Publicis Health Media and Digitas Health before being recruited to rewrite the media playbook at AstraZeneca.In a conversation with Pharma Editor Lecia Bushak, Morrison discusses what receiving the honorific means to her and details her experience as a caregiver to her father, who lives with Alzheimer’s disease.For Trends, we do some cleanup duty on the pharma ads that ran during Super Bowl LX. We talk about how they performed and spotlight some analyses from ad measurement firms. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ahead of the big game, managing editor Jack O’Brien hosts DJ Khaled and Danielle Brooks about starring in Novo Nordisk’s Super Bowl commercial promoting its oral version of the blockbuster drug Wegovy.The statements included in this podcast are the opinion of the participants and do not necessarily reflect the opinion of Novo Nordisk. Novo Nordisk has not endorsed or approved these statements. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

One of the main reasons drugmakers have pivoted ad dollars in this direction is simple: People love sports. So in honor of the release of our Sports Issue, we’re dissecting why about half a dozen pharma brands are lining up to advertise during Super Bowl LX on Sunday. Before we dive into that during our Trends segment, we have a feature interview with a pair of leaders from Avalere Health. Avalere Health CEO Amar Urhekar and U.S. president of marketing Sarah Hall join the show to discuss how the policy-first agency has navigated its health clients through regulatory turbulence to find smoother air and how the 2025 Agency 100 honoree has fared in the first month of 2026.We also talk to Hall about her jump from FCB Health New York to Avalere Health, as well as how Urhekar has added key leadership talent from those who have left the federal government or holding companies over the past year. Now lace up your cleats, grab a glove and get ready to play ball.  Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We begin the show with a remembrance of Alex Pretti, a 37-year-old ICU nurse who was shot and killed by federal agents on the streets of Minneapolis.The killing of Pretti has unnerved the nation as a whole, but also had an even more profound impact on the tight-knit community of front-line workers who serve as the foundation of our healthcare system. In a time of crisis, they are looking for health leaders to meet the moment and offer unconditional support.Not every event in a fast-paced world requires a statement or action from health brands, but when an ICU nurse is the victim of both senseless violence and vicious disinformation, the moment arises.  As for the main interview, pharma editor Lecia Bushak speaks with Haymarket Media colleague Vera Luxner at Rare Disease Advisor about some upcoming initiatives related to Rare Disease Month, which takes place in February.Then, editor-in-chief Jameson Fleming and editor-at-large Steve Madden join the Trends segment to discuss the recent launches of the nomination period for the 2026 Agency 100, the MM+M Awards and the Healthcare Marketers Survey.Music: “Deep Reflection” by DP and Triple Scoop Music. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

You’ll recall that actors Justin Long and John Hodgman achieved advertising fame in the latter part of the 2000s for their participation in Apple’s long-running Get a Mac campaign.Now, the pair have reunited for Novo Nordisk’s There’s Only One Ozempic campaign, which debuted Tuesday morning.In the spots, Long represents Ozempic and its FDA-approved indications, while Hodgman represents “other GLP-1s for type 2 diabetes.”Novo’s latest consumer-focused brand campaign seeks to differentiate Ozempic from other GLP-1 drugs on the market by underscoring its multiple clinical indications for people living with type 2 diabetes. As such the pair are featured in a handful of light-hearted ads that take place in front of a water cooler, a whiteboard and on a game show set.To promote the ad campaign, Long and Hodgman joined managing editor Jack O’Brien for a lively joint interview on this week’s episode of the podcast. In lieu of our Trends segment, we have some audio bites from editor-at-large Steve Madden’s time on the ground at the J.P. Morgan Healthcare Conference in San Francisco. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Few people in medical marketing have as accomplished of a track record as Matt McNally.Over the course of more than three decades, Matt has worked across numerous major holding companies and impacted the industry in innumerable ways.In late 2024, he found his career at an inflection point. Having led Omnicom Health Group for a few years, his future was put in question when Omnicom announced its multibillion dollar takeover of holding company rival IPG. As industry stakeholders speculated about whether he or IPG Health CEO Dana Maiman would lead the new Omnicom Health vertical post-merger, Matt submitted his resignation, effective January 1, 2025. Then, just over a week later, he returned to Publicis to serve as global CEO of Publicis Health. In his first year on the job, Publicis Health has benefited from the robust performance of MM+M Agency 100 honorees like Digitas Health, Heartbeat, Razorfish Health and Saatchi & Saatchi Wellness.Additionally, Publicis Health welcomed medcomms agency P-value Group into the fold over the summer.On this week’s episode, McNally joins us to talk about how his return to Publicis Health has gone, what he makes of the new-look Omnicom and what else is on his radar for 2026. It’s a conversation with a medical marketing tastemaker that you won’t want to miss.For our Trends segment, we have a few updates on those Untitled Letters the FDA has been sending out to drugmakers. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The first episode of the MM+M Podcast in 2026 centers on the bright lights of Las Vegas.Like clockwork, early January in Vegas is dominated by the Consumer Electronics Showcase – which is routinely ranked as the most-attended trade show in the U.S.  While CES is, in accordance with its name, more consumer-focused in nature, the four-day bonanza always offers a healthcare hook.Alison Woo, a former CNN journalist and comms lead for pharma giants like GSK and Novartis, has been stationed in Vegas since media availability began on Sunday.You may remember Alison from the last time she was on the podcast, which was one year ago when she covered CES 2025 for us. This week, Alison and managing editor Jack O’Brien chat about all things CES: the omnipresence of AI, innovation that will actually make a difference in healthcare as well as only the most pertinent medical marketing takeaways for you the listener.And for our Trends segment, we’re discussing some of our medical marketing industry resolutions for 2026 and say goodbye to reporter Heerea Rikhraj.Music: “Deep Reflection” by DP and Triple Scoop Music. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

2025 – what a year that was for medical marketing.So many events and developments contributed to headlines in not only MM+M but mainstream outlets as well.Chief among them was the confirmation of Robert F. Kennedy Jr. as HHS Secretary, which signaled the direction that the second Trump administration would take on health policy.Not to be outdone, AI had a sizable impact, too. The momentum behind AI affected how millions consume information, do their jobs and even the ads they see on a daily basis.  Additionally, the closing of Omnicom’s takeover of IPG sent another shockwave through adland. Though medical marketing shops may be more insulated than consumer agencies, they were not spared.This week, I’m joined by editor-in-chief Jameson Fleming, editor-at-large Steve Madden, pharma editor Lecia Bushak and reporter Heerea Rikhraj so the MM+M editorial team can say ‘goodbye’ to 2025 and ‘hello’ to 2026 in our final episode of the year.And once again, in lieu of the Trends segment, we bring you an interview from our recent AI Deciphered conference, this time with health futurist John Duffield. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, HWP CEO Jani Hegarty and SVP of development operations Justin Schlemm share how Health & Wellness Partners is adopting AI internally — not as a trend, but with rigor, oversight and deep respect for the science and compliance that pharma demands. They discuss how AI is already helping HWP teams extract insights, and stay current on therapeutic trends — all within a strong framework of governance, integrity and human-in-the-loop quality control. The conversation explores how to separate novelty from necessity, and how life-science partners can confidently prepare for an AI-enabled future. Check us out at: mmm-online.com   Follow us:  YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M   To read more of the most timely, balanced and original reporting in medical marketing, subscribe here. Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.